## What is Multi omics?
> Multi-omics refers to the integration of data from multiple "omics" technologies, including genomics, transcriptomics, proteomics, metabolomics, epigenomics, and others, to provide a more complete understanding of biological systems.

> Each omics technology provides a different layer of information about the same biological sample, allowing researchers to study various aspects of the sample, such as the DNA, RNA, proteins, metabolites, and epigenetic modifications. By integrating data from multiple omics technologies, researchers can obtain a more comprehensive view of the molecular processes underlying a particular biological phenomenon or disease.

> Multi-omics approaches are becoming increasingly popular in many areas of research, including personalized medicine, drug discovery, and systems biology. These approaches allow researchers to identify new biomarkers, understand disease mechanisms, and develop more effective diagnostic and treatment strategies.

## Would you please guide me step by step process of drug discovery?
Sure, I can provide a general step-by-step process of drug discovery. Keep in mind that drug discovery can be a long and complex process that can take years and sometimes decades, and the exact steps may vary depending on the disease or condition being targeted.

1. Target identification: The first step in drug discovery is identifying a specific target, such as a protein or enzyme, that is involved in the disease or condition of interest. This target must be well-characterized and have a known role in the disease pathway.
2. Hit discovery: The next step is identifying molecules, known as "hits," that can interact with the target and potentially modulate its activity. This can be done through high-throughput screening of large chemical libraries, virtual screening using computer models, or other methods.
3. Hit-to-lead optimization: Once hits have been identified, the most promising compounds are selected for further optimization. This involves modifying the structure of the hit molecule to improve its potency, selectivity, and pharmacokinetic properties.
4. Lead optimization: From the pool of optimized hits, one or more compounds are selected as leads based on their efficacy, safety, and other factors. These leads are further refined and tested to optimize their properties and improve their chances of success in clinical trials.
5. Preclinical testing: Before a drug can be tested in humans, it must undergo rigorous preclinical testing to evaluate its safety, efficacy, and pharmacokinetics. This typically involves animal studies and other tests to assess the drug's toxicology, pharmacology, and pharmacodynamics.
6. Clinical trials: If a drug passes preclinical testing, it can then proceed to clinical trials, which involve testing the drug in humans to evaluate its safety, efficacy, and dosing. Clinical trials are typically conducted in three phases, with increasing numbers of participants and more rigorous testing at each phase.
7. Regulatory approval: If a drug successfully completes clinical trials and is shown to be safe and effective, it can then be submitted for regulatory approval. This involves submitting a detailed dossier of data to regulatory authorities such as the FDA or EMA, who will evaluate the data to determine if the drug should be approved for use in the general population.
8. Post-market surveillance: Even after a drug is approved, ongoing surveillance is necessary to monitor its safety and efficacy in real-world settings. This involves collecting and analyzing data on the drug's use, adverse events, and other factors to ensure its continued safety and effectiveness.



## What is source of multi-omics data?

> Multi-omics data refers to the collection of multiple types of biological data from an organism, such as genomics, transcriptomics, proteomics, metabolomics, and others.

> The source of multi-omics data varies depending on the type of data being collected. Here are some examples:

* Genomics: DNA sequencing technology is used to generate genomic data, which provides information about an organism's genetic makeup.
* Transcriptomics: RNA sequencing technology is used to generate transcriptomic data, which provides information about the expression of genes in an organism.
* Proteomics: Mass spectrometry is often used to generate proteomic data, which provides information about the proteins present in an organism.
* Metabolomics: Mass spectrometry or nuclear magnetic resonance (NMR) spectroscopy are commonly used to generate metabolomic data, which provides information about the small molecule metabolites in an organism.
In general, the source of multi-omics data involves the use of various laboratory techniques and technologies to generate different types of biological data from an organism. These data are then analyzed and integrated to provide a more comprehensive understanding of the biological processes at play in the organism.

## Give me few source of  multi-omics data which are publicly available for research
> There are several publicly available sources of multi-omics data that researchers can use for their studies. Here are some examples:

* The Cancer Genome Atlas (TCGA): TCGA is a project that has generated multi-omics data on several types of cancer, including genomics, transcriptomics, proteomics, and others. The data are freely available through the National Cancer Institute's Genomic Data Commons (GDC) portal.

* Genotype-Tissue Expression (GTEx) project: GTEx is a project that has generated multi-omics data on human tissues, including genomics, transcriptomics, and proteomics. The data are freely available through the GTEx Portal.

* The Human Cell Atlas (HCA): The HCA project aims to create a comprehensive map of all the cells in the human body. It generates multi-omics data on different types of human cells, including genomics, transcriptomics, and proteomics. The data are freely available through the HCA Data Portal.

* The Encyclopedia of DNA Elements (ENCODE) project: ENCODE generates multi-omics data on the functional elements of the human genome, including genomics, transcriptomics, and epigenomics. The data are freely available through the ENCODE portal.

* The Metabolomics Workbench: The Metabolomics Workbench is a repository of metabolomics data from various organisms, including humans, animals, plants, and microorganisms. The data are freely available through the Metabolomics Workbench website.

These are just a few examples of publicly available sources of multi-omics data. There are many more resources available for researchers, depending on their specific research interests.

### HCA Data Portal.
* https://data.humancellatlas.org
* https://www.humancellatlas.org/data-portal/
* https://gtexportal.org/home/
* https://www.encodeproject.org
* https://openfold.io
* https://github.com/aqlaboratory/openfold
